FindTrial
Sign In

Assessment of pulmonary function test in patients recovered from COVID 19 infection

Assessment of pulmonary function test in patients recovered from COVID 19 infection

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/12/029669
Enrollment
50
Registered
2020-12-09
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

Intervention1: Pulmonary Function Test: Spirometry DLCO MIP MEP MVV Control Intervention1: NOT APPLICABLE: NOT APPLICABLE

Sponsors

Dr Richa Udhwani
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age more than 18 years Previously confirmed COVID positive by rapid antigen or RTPCR swab test Completed one month after positive test Willing to participate and give consent

Exclusion criteria

Exclusion criteria: Unstable patients Non-compliant patients Patients in moribund condition Patients with active viral infection Patients having old pulmonary tuberculosis, Asthma, COPD, ILD and other chronic respiratory diseases Patients having chronic diseases like HIV, malignancy etc

Design outcomes

Primary

MeasureTime frame
To assess pattern of pulmonary functions in patients infected with Covid-19 To assess respiratory muscle strength in patients after Covid-19 infection based on MIP, MEP and MVV.Timepoint: 1 month after covid negative report date—

Secondary

MeasureTime frame
Correlation between symptom severity and pulmonary function test To assess progression of pulmonary functionTimepoint: 2 month after first visit—

Countries

India

Contacts

Public ContactDr Anand Patel

GMERS Medical College and Hospital Gotri Vadodara

dranandkpatel@gmail.com9879771079

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026